Skip to content

Serotonin: all studies

Page 291 of 400: studies 2,901 to 2,910 of 3,999, newest first. Back to the serotonin overview

Research

Baseline Power of Theta Oscillations Predicts Mystical-Type Experiences Induced by DMT in a Natural Setting

Frontiers in Psychiatry November 5, 2021 Enzo Tagliazucchi, Federico Zamberlán, Federico Cavanna et al. 23 citations

N,N-Dimethyltryptamine (DMT) is a classic psychedelic capable of inducing short-lasting but profound changes in consciousness. As with other psychedelics, the experience induced by DMT strongly depends upon contextual factors, yet the neurobiological determinants of this variability remain unknown. The present study investigated changes in neural oscillations elicited by inhaled DMT, and...

DOI: 10.3389/fpsyt.2021.720066 (opens in new tab) Electroencephalography Consciousness Feeling Audiology +1

Psychedelic Experiences During the Early COVID-19 Pandemic: Findings From an International Online Survey

Frontiers in Psychiatry November 4, 2021 Ricarda Evens, Simon Reiche, Roman M. Marek et al. 16 citations

Introduction: The current corona virus disease (COVID-19) pandemic has caused a serious global health crisis that has affected large parts of the public and private life worldwide, including the use of psychoactive substances. In this study, we investigated the effect of the COVID-19 pandemic on the use of serotonergic psychedelics, i.e., the settings in which people use psychedelics, the...

Psychedelic experience dose-dependently modulated by cannabis: results of a prospective online survey.

Psychopharmacology November 4, 2021 Joanna Kuć, Hannes Kettner, Fernando E. Rosas et al. 37 citations

RATIONALE: Classic psychedelics are currently being studied as novel treatments for a range of psychiatric disorders. However, research on how psychedelics interact with other psychoactive substances remains scarce. OBJECTIVES: The current study aimed to explore the subjective effects of psychedelics when used alongside cannabis. METHODS: Participants (n = 321) completed a set of online surveys...

DOI: 10.1007/s00213-021-05999-1 (opens in new tab) Full text (opens in new tab) Psychedelics Cannabis/marijuana/weed Drug interactions Altered states +1

Lysergic acid diethylamide induces increased signalling entropy in rats’ prefrontal cortex

Journal of Neurochemistry November 3, 2021 Aurora Savino, Charles D. Nichols 18 citations

Abstract Psychedelic drugs are gaining attention from the scientific community as potential new compounds for the treatment of psychiatric diseases such as mood and substance use disorders. The 5‐HT 2A receptor has been identified as the main molecular target, and early studies pointed to an effect on the expression of neuroplasticity genes. Analysing RNA‐seq data from the prefrontal cortex of...

Models of psychedelic drug action: modulation of cortical-subcortical circuits

Brain October 22, 2021 Manoj K. Doss, Maxwell B. Madden, Andrew Gaddis et al. 196 citations

Abstract Classic psychedelic drugs such as psilocybin and lysergic acid diethylamide (LSD) have recaptured the imagination of both science and popular culture, and may have efficacy in treating a wide range of psychiatric disorders. Human and animal studies of psychedelic drug action in the brain have demonstrated the involvement of the serotonin 2A (5-HT2A) receptor and the cerebral cortex in...

O Uso da Ayahuasca como terapia alternativa na depressão: efeitos farmacológicos e adversos

Brazilian Journal of Natural Sciences October 12, 2021 Beatriz Souza Silva, Giovanna Pereira Lima, Isabela Rodrigues Alencar Dos Santos et al. 2 citations

Doença comum atualmente, a depressão, quando diagnosticada, é tratada com fármacos antidepressivos, sendo os inibidores seletivos da receptação de serotonina (ISRSs) considerados os de primeira escolha. Tanto esta quanto as demais classes de antidepressivos costumam apresentar efeitos adversos, que muitas vezes levam ao abandono do tratamento pelo paciente. Um outro desafio no tratamento da...

DOI: 10.31415/bjns.v4i2.143 (opens in new tab) Pharmacology Traditional medicine

Many Drugs of Abuse May Be Acutely Transformed to Dopamine, Norepinephrine and Epinephrine In Vivo

International Journal of Molecular Sciences October 2, 2021 Paul J. Fitzgerald 30 citations

It is well established that a wide range of drugs of abuse acutely boost the signaling of the sympathetic nervous system and the hypothalamic–pituitary–adrenal (HPA) axis, where norepinephrine and epinephrine are major output molecules. This stimulatory effect is accompanied by such symptoms as elevated heart rate and blood pressure, more rapid breathing, increased body temperature and...

DOI: 10.3390/ijms221910706 (opens in new tab) Dopamine Norepinephrine In vivo Pharmacology +2

Prolonged epigenomic and synaptic plasticity alterations following single exposure to a psychedelic in mice

Cell Reports October 1, 2021 Mario de la Fuente Revenga, Bohan Zhu, Christopher A. Guevara et al.

SUMMARY Clinical evidence suggests that rapid and sustained antidepressant action can be attained with a single exposure to psychedelics. However, the biological substrates and key mediators of psychedelics’ enduring action remain unknown. Here, we show that a single administration of the psychedelic DOI produces fast-acting effects on frontal cortex dendritic spine structure and acceleration...

Novel antidepressant drugs: Beyond monoamine targets

CNS Spectrums September 30, 2021 Xénia Gonda, Péter Döme, Joanna C. Neill et al. 77 citations

Abstract Treatment of major depressive disorder (MDD) including treatment-resistant depression (TRD) remains a major unmet need. Although there are several classes of dissimilar antidepressant drugs approved for MDD, the current drugs have either limited efficacy or are associated with undesirable side effects and withdrawal symptoms. The efficacy and side effects of antidepressant drugs are...

DOI: 10.1017/s1092852921000791 (opens in new tab) Major depressive disorder Antidepressant Monoamine neurotransmitter Tolerability +2

Psychedelics, Sociality, and Human Evolution

Frontiers in Psychology September 29, 2021 José Manuel Rodríguez-arce, Michael James Winkelman 80 citations

Our hominin ancestors inevitably encountered and likely ingested psychedelic mushrooms throughout their evolutionary history. This assertion is supported by current understanding of: early hominins’ paleodiet and paleoecology; primate phylogeny of mycophagical and self-medicative behaviors; and the biogeography of psilocybin-containing fungi. These lines of evidence indicate mushrooms...

DOI: 10.3389/fpsyg.2021.729425 (opens in new tab) Sociality Context archaeology Cognition Cognitive psychology +1